Chen L W, Jan C R
Department of Surgery, Kaohsiung Veterans General Hospital, 386 Ta Chung 1st Rd., Kaohsiung 813, Taiwan.
Int Immunopharmacol. 2001 Jul;1(7):1341-9. doi: 10.1016/s1567-5769(01)00066-2.
The effect of fMLP (N-formyl-methionyl-leucyl-phenylalanine), a neutrophil-stimulating bacterial peptide, on Ca2+ mobilization in human neutrophils was examined using fura-2 as a Ca2+ indicator. fMLP (10 nM-10 microM) increased [Ca2+]i concentration-dependently. The [Ca2+]i signal comprised an initial rise followed by a gradual decay and a sustained phase. External Ca2+ removal partly decreased the signal. La3+ (50 microM) pretreatment mimicked the effect of Ca2+ removal. In Ca(2+)-free medium, pretreatment with 1 microM thapsigargin (an endoplasmic reticulum Ca2+ pump inhibitor) prevented 10 microM fMLP from increasing [Ca2+]i; whereas 1 microM thapsigargin still significantly increased [Ca2+]i after pretreatment with 10 microM fMLP. Addition of 3 mM Ca2+ induced a concentration-dependent [Ca2+]i increase after pretreatment with fMLP in Ca(2+)-free medium. This Ca2+ entry was partly inhibited by econazole (25 microM), SKF96365 (50 microM), and a phospholipase A2 inhibitor (aristolochic acid; 20 microM). The fMLP (10 microM)-induced Ca2+ release was abolished by inhibiting phospholipase C with 2 microM U73122. The fMLP-induced [Ca2+]i increase was inhibited by 25% by pretreatment with 10 nM phorbol ester to activate protein kinase C but was augmented by 27% by pretreatment with 2 microM GF 109203X to inactivate protein kinase C. We found that fMLP increase reactive oxygen intermediate (ROI) production in neutrophils, which can be suppressed by U73122 pretreatment. Collectively, this study shows that in human neutrophils, fMLP increased [Ca2+]i concentration-dependently by releasing Ca2+ from phospholipase C-coupled, thapsigargin-sensitive stores, accompanied by Ca2+ entry. The fMLP-induced [Ca2+]i rise was modulated by protein kinase C, and the fMLP-induced Ca2+ entry was abolished by La3+, and was reduced by econazole, SKF96365 and inhibition of phospholipase A2.
以fura - 2作为钙指示剂,研究了一种刺激中性粒细胞的细菌肽N - 甲酰甲硫氨酰 - 亮氨酰 - 苯丙氨酸(fMLP)对人中性粒细胞中钙离子动员的影响。fMLP(10 nM - 10 μM)呈浓度依赖性增加细胞内钙离子浓度([Ca2+]i)。[Ca2+]i信号包括一个初始上升,随后是逐渐衰减和一个持续阶段。去除细胞外钙离子部分降低了该信号。用50 μM镧离子(La3+)预处理模拟了去除钙离子的效果。在无钙培养基中,用1 μM毒胡萝卜素(一种内质网钙泵抑制剂)预处理可阻止10 μM fMLP增加[Ca2+]i;而在用10 μM fMLP预处理后,1 μM毒胡萝卜素仍能显著增加[Ca2+]i。在无钙培养基中用fMLP预处理后,添加3 mM钙离子会引起浓度依赖性的[Ca2+]i增加。这种钙离子内流部分受到酮康唑(25 μM)、SKF96365(50 μM)和一种磷脂酶A2抑制剂(马兜铃酸;20 μM)的抑制。用2 μM U73122抑制磷脂酶C可消除fMLP(10 μM)诱导的钙离子释放。用10 nM佛波酯预处理以激活蛋白激酶C可使fMLP诱导的[Ca2+]i增加受到25%的抑制,但用2 μM GF 109203X预处理以失活蛋白激酶C可使其增加27%。我们发现fMLP可增加中性粒细胞中活性氧中间体(ROI)的产生,而U73122预处理可抑制这种产生。总体而言,本研究表明,在人中性粒细胞中,fMLP通过从与磷脂酶C偶联的、对毒胡萝卜素敏感的储存库释放钙离子,并伴有钙离子内流,呈浓度依赖性增加[Ca2+]i。fMLP诱导的[Ca2+]i升高受到蛋白激酶C的调节,fMLP诱导的钙离子内流被La3+消除,并被酮康唑、SKF96365和磷脂酶A2的抑制所降低。